SOMERVILLE, N.J., June 6, 2017 /PRNewswire/ -- Uncontrolled bleeding during surgery can adversely affect patient outcomes, hospital costs and resources. 1-9 Primary methods of hemostasis alone may be ...
Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the launch of PERCLOT Absorbable Hemostatic Powder in the U.S. PERCLOT is a passive, absorbable ...
The leading cause of death due to injuries in war is excessive bleeding. A KAIST research team, in which an Army Major ...
Baxter launches the Hemopatch Sealing Hemostat, a room-temperature collagen pad approved for Hemostasis and Sealing. Baxter International Inc. (NYSE: BAX), a renowned leader in pioneering surgical ...
MarketsandResearch.biz has updated its database by adding Global Absorbable Hemostat Powder Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 which delivers an extensive ...
Marks first passive hemostat for Baxter in the U.S. market, broadening portfolio offering to include a full range of active and passive hemostatic products PERCLOT further enhances clinicians’ ability ...
“PERCLOT is a strong complement to Baxter’s leading hemostat portfolio,” said Steve Wallace, president, Advanced Surgery at Baxter. “The launch of PERCLOT in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback